Skip to main content

Lyt-200

Pancreatic News & Updates
Pancreatic Cancer Treatment

FDA Grants Orphan Drug Designation to LYT-200 for Pancreatic Cancer and being evaluated in Cholangiocarcinoma

By Dr. C.H. Weaver M.D.